Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease.
Aye S, Johansson G, Hock C, Lannfelt L, Sims JR, Blennow K, Frederiksen KS, Graff C, Molinuevo JL, Scheltens P, Palmqvist S, Schöll M, Wimo A, Kivipelto M, Handels R, Frölich L, Zilka N, Tolar M, Johannsen P, Jönsson L, Winblad B.
Aye S, et al. Among authors: sims jr.
J Prev Alzheimers Dis. 2025 Jan;12(1):100022. doi: 10.1016/j.tjpad.2024.100022. Epub 2025 Jan 1.
J Prev Alzheimers Dis. 2025.
PMID: 39800469